Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Le Ferment is a French biotechnology company and a subsidiary of the Greentech Group, specializing in the large-scale production of microorganisms through precision fermentation. The company provides contract manufacturing and development services (CDMO) for the health, cosmetic, and environmental sectors, focusing on bacteria, yeasts, and fungi. Their expertise spans from strain selection and optimization to industrial-scale production of biomass and metabolites. By leveraging advanced fermentation technologies, Le Ferment supports the development of innovative solutions in probiotics, postbiotics, and live biotherapeutics. The company operates a state-of-the-art facility at the Biopôle Clermont-Limagne, designed to meet high quality standards for international markets. Their services enable partners to accelerate the transition from laboratory research to industrial commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Le Ferment.